Transient Leukopenia Induced by Combination Therapy for Severe SARS-CoV-2 Pneumonia

Treatment strategies for patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to be heavily researched and ever-changing. Recent data has suggested that combination therapy with dexamethasone, remdesivir and baricitinib could decrease the severity and length of illness...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Sierra, Leelaviwat, Natnicha, Davalos, Jesus, Evans, Abbie, Abdelnabi, Mahmoud, Mittal, Neha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678126/
https://www.ncbi.nlm.nih.gov/pubmed/36415839
http://dx.doi.org/10.12890/2022_003636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678126/
https://www.ncbi.nlm.nih.gov/pubmed/36415839
http://dx.doi.org/10.12890/2022_003636

Ejemplares similares